C

CareDx
D

CDNA

20.630
USD
1.37
(7.11%)
مفتوح الان
حجم التداول
54,566
الربح لكل سهم
-0
العائد الربحي
-
P/E
18
حجم السوق
1,148,689,726
أصول ذات صلة
ABT
ABT
-1.290
(-0.97%)
132.190 USD
BDX
BDX
-0.140
(-0.08%)
174.500 USD
DGX
DGX
-1.080
(-0.63%)
171.460 USD
HOLX
HOLX
0.230
(0.35%)
65.130 USD
IDXX
IDXX
-3.77
(-0.70%)
534.93 USD
ILMN
ILMN
-3.150
(-3.17%)
96.170 USD
PODD
PODD
1.35
(0.46%)
297.86 USD
TMO
TMO
-11.03
(-2.59%)
415.11 USD
المزيد
الأخبار المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.